Pacira BioSciences (PCRX) Income from Continuing Operations (2010 - 2026)
Pacira BioSciences' Income from Continuing Operations came in at $4.65 million for Q2 2026, compared with -$4.85 million a year earlier and up 59.6% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Pacira BioSciences reported Income from Continuing Operations of $14.64 million; for FY2025, it was $7.03 million.
- Income from Continuing Operations carries a five-year compound annual growth rate of -45.4% (FY2020 to FY2025).
- Going back by year, Income from Continuing Operations was -$99.56 million in FY2024, $41.96 million in FY2023 (+163.7%), $15.91 million in FY2022 (-62.1%) and $41.98 million in FY2021 (-71.2%).
- The five-year range for quarterly Income from Continuing Operations is -$143.47 million (Q3 2024) to $25.76 million (Q2 2023).
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q2 2023 (growth of 29.6%), and the weakest in Q4 2025 (a decline of 89.8%).
- Business Quant data shows PCRX's Income from Continuing Operations at $2.92 million (Q1 2026), $1.64 million (Q4 2025) and $5.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn | 4.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.65 Mn |
| Mar 31, 2026 | 2.92 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | -4.85 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 16.04 Mn |
| Sep 30, 2024 | -143.47 Mn |
| Jun 30, 2024 | 18.89 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 24.87 Mn |
| Sep 30, 2023 | 10.86 Mn |
| Jun 30, 2023 | 25.76 Mn |
| Mar 31, 2023 | -19.54 Mn |
| Dec 31, 2022 | -10.10 Mn |
| Sep 30, 2022 | -693,000.00 |
| Jun 30, 2022 | 19.88 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Dec 31, 2021 | -5.13 Mn |
| Sep 30, 2021 | 17.66 Mn |
API Access
Pacira BioSciences Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();